These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 33806890)

  • 21. A population-based survey of self-reported delays in breast, cervical, colorectal and lung cancer screening.
    Gunn CM; Berrian K; Weiss JE; Tosteson AAN; Hasson RM; Di Florio-Alexander R; Peacock JL; Rees JR
    Prev Med; 2023 Oct; 175():107649. PubMed ID: 37517458
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Breast, Cervical, and Colorectal Cancer Screening Adherence: Effect of Low Body Mass Index in Women.
    Charkhchi P; Schabath MB; Carlos RC
    J Womens Health (Larchmt); 2020 Jul; 29(7):996-1006. PubMed ID: 31928405
    [No Abstract]   [Full Text] [Related]  

  • 23. The influence of marital status on the use of breast, cervical, and colorectal cancer screening.
    Hanske J; Meyer CP; Sammon JD; Choueiri TK; Menon M; Lipsitz SR; Noldus J; Nguyen PL; Sun M; Trinh QD
    Prev Med; 2016 Aug; 89():140-145. PubMed ID: 27215758
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Organizational Factors Affecting the Likelihood of Cancer Screening Among VA Patients.
    Chou AF; Rose DE; Farmer M; Canelo I; Yano EM
    Med Care; 2015 Dec; 53(12):1040-9. PubMed ID: 26569643
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Adherence to Guideline-Recommended cancer screening among Utah cancer survivors.
    Millar MM; Edwards SL; Herget KA; Orleans B; Ofori-Atta BS; Kirchhoff AC; Carter ME; Nagata M; Sweeney C
    Cancer Med; 2023 Feb; 12(3):3543-3554. PubMed ID: 36029153
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Oncological organized screening programmes in the COVID-19 era: an Italian survey on accrued delays, reboot velocity, and diagnostic delay estimates].
    Mantellini P; Battisti F; Armaroli P; Giubilato P; Ventura L; Zorzi M; Battagello J; Sassoli de Bianchi P; Senore C; Zappa M
    Epidemiol Prev; 2020; 44(5-6 Suppl 2):344-352. PubMed ID: 33412828
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cervical and breast cancer screening participation for women with chronic conditions in France: results from a national health survey.
    Constantinou P; Dray-Spira R; Menvielle G
    BMC Cancer; 2016 Mar; 16():255. PubMed ID: 27029643
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Methods to increase participation in organised screening programs: a systematic review.
    Camilloni L; Ferroni E; Cendales BJ; Pezzarossi A; Furnari G; Borgia P; Guasticchi G; Giorgi Rossi P;
    BMC Public Health; 2013 May; 13():464. PubMed ID: 23663511
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Correlates of non-adherence to breast, cervical, and colorectal cancer screening among screen-eligible women: a population-based cohort study in Ontario, Canada.
    Vahabi M; Lofters AK; Kopp A; Glazier RH
    Cancer Causes Control; 2021 Feb; 32(2):147-155. PubMed ID: 33392906
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Patient Navigation for Comprehensive Cancer Screening in High-Risk Patients Using a Population-Based Health Information Technology System: A Randomized Clinical Trial.
    Percac-Lima S; Ashburner JM; Zai AH; Chang Y; Oo SA; Guimaraes E; Atlas SJ
    JAMA Intern Med; 2016 Jul; 176(7):930-7. PubMed ID: 27273602
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The impact of COVID-19 on screening for colorectal, gastric, breast, and cervical cancer in Korea.
    Park H; Seo SH; Park JH; Yoo SH; Keam B; Shin A
    Epidemiol Health; 2022; 44():e2022053. PubMed ID: 35760396
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Concurrent participation in breast, cervical, and colorectal cancer screening in the Netherlands.
    Kregting LM; Olthof EMG; Breekveldt ECH; Aitken CA; Heijnsdijk EAM; Toes-Zoutendijk E; de Koning HJ; van Ravesteyn NT
    Eur J Cancer; 2022 Nov; 175():180-186. PubMed ID: 36126478
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Associations of multimorbidity with breast, cervical, and colorectal cancer screening delivery: a cross-sectional study of a nationally representative Japanese sample.
    Yamashita H; Takahashi Y; Ishizaki T; Imura H; Nakayama T
    Cancer Epidemiol; 2020 Dec; 69():101798. PubMed ID: 32980753
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of financial incentives on breast, cervical and colorectal cancer screening delivery rates: Results from a systematic literature review.
    Mauro M; Rotundo G; Giancotti M
    Health Policy; 2019 Dec; 123(12):1210-1220. PubMed ID: 31587819
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cancer Screening on the Hopi Reservation: A Model for Success in a Native American Community.
    Brown SR; Joshweseoma L; Saboda K; Sanderson P; Ami D; Harris R
    J Community Health; 2015 Dec; 40(6):1165-72. PubMed ID: 26091896
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Temporal Trend in Uptake of the National General Health Checkups and Cancer Screening Program among Korean Women with Breast Cancer.
    Tran TXM; Kim S; Cha C; Park B
    Cancer Res Treat; 2024 Apr; 56(2):522-530. PubMed ID: 37905311
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Socioeconomic factors affecting colorectal, breast and cervical cancer screening in an Asian urban low-income setting at baseline and post-intervention.
    Wee LE; Koh GC; Chin RT; Yeo WX; Seow B; Chua D
    Prev Med; 2012 Jul; 55(1):61-7. PubMed ID: 22561028
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Exploring Knowledge, Attitudes, and Practices Related to Breast and Cervical Cancers in Mongolia: A National Population-Based Survey.
    Yerramilli P; Dugee O; Enkhtuya P; Knaul FM; Demaio AR
    Oncologist; 2015 Nov; 20(11):1266-73. PubMed ID: 26417038
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A national quality improvement study identifying and addressing cancer screening deficits due to the COVID-19 pandemic.
    Joung RH; Nelson H; Mullett TW; Kurtzman SH; Shafir S; Harris JB; Yao KA; Brajcich BC; Bilimoria KY; Cance WG
    Cancer; 2022 Jun; 128(11):2119-2125. PubMed ID: 35307815
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Obstacles to the uptake of breast, cervical, and colorectal cancer screenings: what remains to be achieved by French national programmes?
    Sicsic J; Franc C
    BMC Health Serv Res; 2014 Oct; 14():465. PubMed ID: 25282370
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.